Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Australian Clinical Labs.
RELATED STOCKHEAD STORIES
Experts
Blood is thicker this quarter: Part 3. Australian Clinical Labs
Experts
Blood is thicker this quarter: Morningstar’s pathological outliers. Part 1. Sonic Healthcare
Experts
MoneyTalks: The most irresistible ASX small cap takeover targets in 2024
Health & Biotech
ScoPo’s Powerplays: ASX healthcare 0.3% up as focus shifts to M&A activity in 2024
Health & Biotech
ASX Health Stocks: ACCC shoots down merger between pathology stocks ACL and Healius
News
Short & Caught: Pilbara Minerals is the ASX’s most shorted as lithium prices tumble
News
ASX Death Cap Lunch Wrap: Local stocks are higher on Friday at noon – we’re sticking to sandwiches
News
Short & Caught: Pilbara Minerals in the crosshairs as lithium plays targeted
News
ASX Large Caps: Iron ore, uranium, coal stocks rally; Aussie job market blows away forecast
Health & Biotech
ASX Health Stocks: BPH wants to ramp up bird’s nest sales to China
Health & Biotech
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
News
ASX Large Caps: Latitude’s cyber theft 40x bigger than first thought; expert says investors could rotate from safe stocks
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
News
ASX Large Caps: Shares sharply down over bank angst, gold shares still go-to haven
Health & Biotech
ASX Health Stocks: Healius gets takeover offer from company less than half its size
News
You don’t have to buy blue chips to earn dividends. These are the top 10 ASX small caps that pay divvies
Experts
